RxDoctor Payments Data

Debra Olcsvay, PA

Physician Assistant · Pottsville, PANPI 1407829963

Payments from drug & device makers

$309in general payments, 2019–2025

Across 17 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$68
  • GSK$53
  • Lilly USA, LLC$46
  • AstraZeneca$34
  • Novartis$19
  • Lexicon Pharmaceuticals, Inc.$17
  • plus $72 from 5 others

What the payments were for

  • Food & beverage$309100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$309 in reported general payments places this provider in the 60th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$75,024
Medicare patients
325
Services billed
1,314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban43$47,580
OzempicSemaglutide33$47,029
XifaxanRifaximin12$45,565
JardianceEmpagliflozin46$39,760
TrulicityDulaglutide20$25,288
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$14,732
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,051
Buprenorphine11$5,361
Albuterol Sulfate HfaAlbuterol Sulfate107$3,969
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$3,853
Dexlansoprazole DrDexlansoprazole15$3,691
Arnuity ElliptaFluticasone Furoate12$3,267
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,459
Atorvastatin Calcium169$2,209
Gabapentin99$1,909

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$68$47,02933 claims
Boehringer IngelheimJardiance$13$39,76046 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta$53$27,04951 claims
Lilly USA, LLCTrulicity$46$25,28820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Pottsville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →